Literature DB >> 1758742

Hyperinflation in children with liver disease due to alpha-1-antitrypsin deficiency.

M F Hird1, A Greenough, G Mieli-Vergani, A P Mowat.   

Abstract

Fifty-nine patients (median age 6.0 years) with liver disease and ten healthy children without liver disease (median age 7.5 years) had serial measurements of functional residual capacity (FRC) over a period of at least 6 months. Twenty-eight children with alpha-1-antitrypsin deficiency (A1ATD) tended to have higher lung volumes than 26 with extrahepatic biliary atresia (EHBA). Fifteen children had persistent hyperinflation (FRC greater than 120% predicted for height; 2 SD above the mean of controls); in five children (four with A1ATD) this was unresponsive to bronchodilator therapy. Two of the children with A1ATD who had persistent unresponsive hyperinflation on three serial measurements were only 3 and 4 years of age. No healthy child without liver disease was hyperinflated. These results suggest that A1ATD may be associated with lung function abnormalities even in very young children.

Entities:  

Mesh:

Year:  1991        PMID: 1758742     DOI: 10.1002/ppul.1950110306

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

Review 1.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

2.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

3.  The effect of variations in positive end expiratory pressure on gas exchange in ventilated children with liver disease.

Authors:  R I Russell; A Greenough; F Giffin
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

4.  Pulmonary function in children with homozygous alpha1-protease inhibitor deficiency.

Authors:  W Wiebicke; B Niggemann; A Fischer
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Effect of positive end expiratory pressure and mean airway pressure on respiratory compliance and gas exchange in children with liver disease.

Authors:  F Giffin; A Greenough
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

6.  Biological Treatments and Target Therapies for Pediatric Respiratory Medicine: Not Only Asthma.

Authors:  Sergio Ghirardo; Michele Mazzolai; Antonio Di Marco; Francesca Petreschi; Nicola Ullmann; Marta Lucia Ciofi Degli Atti; Renato Cutrera
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.